Calamos Advisors LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$1,359,000233,4520.01%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders